Skip to content

Advertisement

  • Research article
  • Open Access
  • Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Accumulation of HIV-1 drug resistance in patients on a standard thymidine analogue-based first line antiretroviral therapy after virological failure: implications for the activity of next-line regimens from a longitudinal study in Mozambique

  • Andrea De Luca1Email author,
  • Zita Jorge Sidumo2,
  • Giacomo Zanelli1,
  • Noorjehan Abdul Magid2,
  • Richard Luhanga3,
  • Davide Brambilla4,
  • Giuseppe Liotta5,
  • Sandro Mancinelli5,
  • Maria Cristina Marazzi6,
  • Leonardo Palombi5 and
  • Susanna Ceffa4
BMC Infectious DiseasesBMC series – open, inclusive and trusted201717:605

https://doi.org/10.1186/s12879-017-2709-x

Received: 26 March 2017

Accepted: 29 August 2017

Published: 5 September 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
26 Mar 2017 Submitted Original manuscript
14 Jul 2017 Reviewed Reviewer Report - Dara Lehman
21 Jul 2017 Reviewed Reviewer Report - Ravi Gupta
16 Aug 2017 Author responded Author comments - Andrea De Luca
Resubmission - Version 2
16 Aug 2017 Submitted Manuscript version 2
28 Aug 2017 Author responded Author comments - Andrea De Luca
Resubmission - Version 3
28 Aug 2017 Submitted Manuscript version 3
Publishing
29 Aug 2017 Editorially accepted
5 Sep 2017 Article published 10.1186/s12879-017-2709-x

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
UOC Malattie Infettive Universitarie, AOU Senese and Department of Medical Biotechnologies, Siena University Hospital, Siena, Italy
(2)
DREAM Program, Maputo, Mozambique
(3)
DREAM Program, Malawi and UPO (Università del Piemonte Orientale), Novara, Italy
(4)
DREAM Program, Rome, Italy
(5)
University of Tor Vergata, Rome, Italy
(6)
University LUMSA, Rome, Italy

Advertisement